Ostarine would be the closest SARM to being accepted in medication which is currently in phase II clinical trials. Like SARMs normally, MK-2866 targets androgen receptors over a selective foundation and avoids making the kinds of dangerous side effects connected with substances like testosterone, human growth hormone, or anabolic steroids, https://algirdasl543xmd0.wikilentillas.com/user